Vaccinating pregnant women can prevent respiratory syncytial virus bronchiolitis in infants

Carlos Ochoa Sangrador^a, Enrique Rodríguez-Salinas Pérez^b

^aServicio de Pediatría. Hospital Virgen de la Concha. Zamora. España.
^bPediatra. CS Colmenar Viejo Norte. Colmenar Viejo. Madrid. España.

Correspondence: C Ochoa. E-mail: cochoas2@gmail.com

Reference of this article: Ochoa Sangrador C, Rodríguez-Salinas Pérez E. Vaccinating pregnant women can prevent respiratory syncytial virus bronchiolitis in infants . Rev Pediatr Aten Primaria. 2024;26:93-6. https://doi.org/10.60147/cccb7ec7

Published in Internet: 20-03-2024 - Visits: 4499

Abstract

Authors´ conclusions: prefusion F protein vaccine against respiratory syncytial virus administered to pregnant women in the last trimester of pregnancy prevents this virus severe respiratory infections in their infants, without important adverse effects. Reviewers´ commentary: the vaccine appears effective and safe, although its efficacy estimates are imprecise. It constitutes an alternative preventive option to the administration of nirsevimab in the newborn, with comparable impact expectations.

Keywords

● Bronchiolitis ● Immunization ● Respiratory syncytial virus ● Vaccines

Note:

Este artículo se publica simultáneamente con la revista electrónica Evidencias en Pediatría (www.evidenciasenpediatria.es).

Comments

This article has no comments yet.